FDA Peptide Reclassification 2026: What It Means for Providers FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn FDA takes first step in possible reversal of ban on some peptides The Washington Post Have you thought about taking peptides that aren't approved by the FDA? Think again. CBS News' chief medical correspondent, @drlapook, shares a cautionary tale from medical history about why testing medications is The FDA's Current Position on Peptides Explained Holt Law